期刊文献+

类风湿性关节炎IL-17检测的临床应用价值研究 被引量:14

The study aimed at clinical application value about the testing ofrheumatoid arthritis IL-17
下载PDF
导出
摘要 目的研究类风湿性关节炎患者关节液和血清中IL-17的含量与其它非免疫性关节损伤IL-17含量差异性,为探讨RA患者的关节损伤机制提供科学依据。方法应用ELISA方法定量检测40例RA组关节液和血清IL-17的含量;检测40例半月板损伤组关节液和血清IL-17的含量;检测40例正常对照组血清IL-17的含量。应用t检验比较各组间的差异性。结果 RA组中,关节液的IL-17含量明显高于血清中的IL-17含量(P<0.01);RA组关节液中的IL-17含量高于半月板损伤组(病例对照组)关节液中的IL-17含量(P<0.01);血清IL-17定量检测结果显示,RA组明显高于病例对照组和正常对照组(P<0.01);而病例对照组与正常对照组比较,IL-17含量无显著性差异(P>0.05)。结论 RA组关节液和血清中均具有较高的IL-17检测值,证实RA患者体内存在细胞免疫应答异常,IL-17是RA患者关节滑膜损伤的重要因素之一。 Objective In order to provide the scientific evidence for the discussion about the joint injury mechanism of those RA patients,the paper mainly analyzed thedifference of IL-17 content between synovial fluid and serum of those RA patients and other non-immune joint injury.Methods NO.1quantitative determination about 40 cases of IL-17 content from those RA patients' synovial fluid and serum by applying ELISA,NO.2the detection about the IL-17 content of synovial fluid and serum from the patients with meniscus injury;NO.3the detection about the IL-17 content ofsynovial fluid and serum from the normal group;NO.4compare the difference among those groups by T-testing.Results in the RA group,the IL-17 content ofsynovial fluid is obviously higher than in the serum(P〈0.01);the IL-17 content ofsynovial fluid in the RA group is higher than in the meniscus injury group(P〈0.01);according to the testing result about quantitative determination of serum IL-17,RA group is much higher than the case control group and normal group(P〈0.01);there is no obvious difference of IL-17 content between the case control group and normalgroup(P〉0.05);Conclusion there is higher IL-17 content in RA patients' synovial fluid and serum,so it can verify the cellullar immunologic response Abnormalityof those RA patients;in a word,IL-17 is the significant factor of Joint synovial injury.
出处 《中国实验诊断学》 2014年第11期1797-1799,共3页 Chinese Journal of Laboratory Diagnosis
基金 吉林市科技发展计划项目(吉市科社字2008033)
关键词 类风湿性关节炎 白细胞介素17 辅助性T细胞17 rheumatoid arthritis(RA) interleukin 17(IL-17) T helper cell 17(Th17)
  • 相关文献

参考文献7

  • 1Cai L, Yin JP, Starovasnik MA, et al. Pathways by which inter- leukin 17 induces articular cartilage breakdown in vitro and in vi- vo[J]. Cytokine,2001,16(1) :10.
  • 2Le Grand A, Fermor B, Fink C, et al. Interleuking-1, tumor necro- sis factor alpha,and interleukin 17 synergistically up-regulate ni- tric oxid and prostaglandin E2 production in explants of human esteciarthritic knee memisci [J]. Arthritis Rheum, 2001,44 ( 9 ) :2078.
  • 3Toy D,Kugler D Wolfson M,et al. Cutting edge: interleukin 17 signals through a heterumeric receptor complex[J]. J Immunol, 2006,177(1) :36.
  • 4Harrington IE, Hatton RD, Mangan PR, et al. Interleukin 17 pro- ducing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages[J]. Nat Immunol, 2005, 6 (11) :1123.
  • 5Afzli B,Lombardi G,Lechler RI,et al. The role of T helper 17 (Thl7) and regulatory T cells (Treg) in human organ transplan tation and autoimmune disease[J]. Clin Exp Immunol, 2007,148 (1) :32.
  • 6Hwang SY, Kim JY, Kim KE, et al. IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial filroblasts via NF- kappaB-and PI3 kinase/Ake-dependent pathways [J]. Arthritis Res Ther,2004,6(2) :R120.
  • 7Greenhough A, Smartt H J, Moore AE, et al. The COX- 2/PGE2 path- way: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment[J]. Carcinogenesis,2009,30(3) : 377.

同被引文献201

引证文献14

二级引证文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部